GSC
MIRM icon

Ground Swell Capital’s Mirum Pharmaceuticals MIRM Stock Holding History

Ground Swell Capital’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,780
Closed -$369K – 229
2024
Q2 		$369K Buy
+10,780
New +$283K 0.29% 43

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ground Swell Capital's MIRM Position: Q3 2024 in Review

Ground Swell Capital sold out of Mirum Pharmaceuticals (MIRM) in Q3 2024, closing a stake of 10,780 shares — an estimated $369K sold.

Ground Swell Capital first reported a position in MIRM in Q2 2024 and held it in 1 quarter. The position peaked at $369K in Q2 2024. 178 funds tracked by Wall St. Rank hold MIRM as of Q3 2024.

  • Ground Swell Capital reported no remaining Mirum Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Ground Swell Capital sold 10,780 Mirum Pharmaceuticals shares in Q3 2024, an estimated $369K.
  • Ground Swell Capital first reported a position in Mirum Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Ground Swell Capital's Mirum Pharmaceuticals position peaked at $369K in Q2 2024.
  • 178 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2024.

Based on Ground Swell Capital's 13F filing for Q3 2024, filed 29 Oct 2024.